[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100490143":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":34,"centralContacts":39,"locations":48,"responsibleParty":71,"collaborators":10,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":10,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":10,"enrollmentInfo":82,"targetDuration":10,"studyType":85,"phases":10,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":50,"whyStopped":10,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with arrhythmia-induced cardiomyopathy (retrospective\u002Fprospective)",null,"retrospective cohort and case-control study followed by a prospective observational cohort study.",[13,14,15,16],"Other: Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)","Other: Data collection: Quality of Life (QoL) Questionnaire (prospective part)","Other: Data collection (retrospective study)","Other: Data collection (prospective study database)",[18,22,26,30],{"type":6,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)","Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part). The assessment will be done via mail, letter or phone",[9],{"type":6,"name":23,"description":24,"armGroupLabels":25,"otherNames":10},"Data collection: Quality of Life (QoL) Questionnaire (prospective part)","Data collection: Quality of Life (QoL) Questionnaire (prospective part). The questionnaire \"EQ-5D-5L questionnaire\" will be used to assess quality of life.",[9],{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":10},"Data collection (retrospective study)","Anonymized search and review of patients electronic health records of the University Hospital of Basel for patients with a reduced LVEF and a concomitant (±1year or after any observation of a reduced LVEF in imaging) diagnosis of arrhythmia known to be causing AiCM.",[9],{"type":6,"name":31,"description":32,"armGroupLabels":33,"otherNames":10},"Data collection (prospective study database)","Data collection on alcohol consumption, family history, rhythm disorder, hospitalizations, cardiac assessments, adverse events at baseline, 6 months, 1 year, 2 years and 5 years.",[9],[35],{"name":36,"affiliation":37,"role":38},"Patrick Badertscher, MD","University Hospital Basel, Department of Cardiology","PRINCIPAL_INVESTIGATOR",[40,44],{"name":36,"role":41,"phone":42,"phoneExt":10,"email":43},"CONTACT","+41 61 556 58 23","patrick.badertscher@usb.ch",{"name":45,"role":41,"phone":46,"phoneExt":10,"email":47},"Jeanne du Fay de Lavallaz, MD-PhD","+41 61 328 76 44","jeanne.dufay@usb.ch",[49],{"facility":37,"status":50,"city":51,"state":10,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"RECRUITING","Basel","4031","Switzerland","CH",{"type":56,"coordinates":57},"Point",[58,59],7.57327,47.55839,{"lat":59,"lon":58},[62,63,67,68,70],{"name":36,"role":41,"phone":42,"phoneExt":10,"email":43},{"name":64,"role":41,"phone":65,"phoneExt":10,"email":66},"Teodor Serban, Dr. med.","+41 77 911 39 08","teodor.serban@usb.ch",{"name":36,"role":38,"phone":10,"phoneExt":10,"email":10},{"name":45,"role":69,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"name":64,"role":69,"phone":10,"phoneExt":10,"email":10},{"type":72,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100490143","characterization-of-arrhythmia-induced-cardiomyopathy-100490143",false,"NCT05662293","Characterization of Arrhythmia-induced Cardiomyopathy","Arrhythmia-induced Cardiomyopathy - a Prospective Observational Cohort Study","Prospective part\n\nInclusion Criteria:\n\n* Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics\n* Signed study consent\n\nExclusion Criteria:\n\n* Patient's active refusal of the general consent of the University Hospital Basel\n* Age \\\u003C18 years old\n* Temporary exclusion criteria: Acute health condition such as myocardial infarction, patients presenting with a major trauma, a sepsis, patients shortly after cardiac surgery, and patients in shock (\\>100 bpm, \\\u003C90 systolic BP, evidence of organ dysfunction).\n* Life expectancy \\\u003C1 year (palliative, terminal cancer)\n\nRetrospective part\n\nInclusion Criteria:\n\n* Patients with a reduced left-ventricular ejection fraction (LVEF ≤50%) or a reduction of 15% in the ejection fraction (EF) between two echocardiographies and a concomitant diagnosis of any arrhythmia likely to lead to AiCM within one year before or after diagnosis of the reduced LVEF from 2010-2021\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years old\n* Patient's active refusal of the general consent of the University Hospital Basel\n* Acute event clearly leading to an acutely reduced LVEF (massive type I myocardial infarction, cardiogenic shock from a coronary or myocardial etiology, septic shock leading to toxic myopathy, hypovolemic shock with reduced EF, cardiac arrest and\u002For need for resuscitation).\n* Patients with life expectancy \\\u003C1 year (palliative, terminal cancer)","ALL","18 Years",{"count":83,"type":84},2700,"ESTIMATED","OBSERVATIONAL","The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.",[88,89],"Cardiomyopathy","Arrhythmia-induced Cardiomyopathy (AiCM)",[91,92,93,94,95,96],"atrial fibrillation (AF)","supraventricular tachycardia (SVT)","ventricular tachycardia","atrial flutter","Major Adverse Cardiovascular Event (MACE)","cardiac arrhythmia","2025-03-03",{"date":99,"type":100},"2025-03-04","ACTUAL",{"date":102,"type":100},"2021-06-10",{"date":104,"type":84},"2027-01",{"name":5,"class":6},1]